MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of investments
$50,960K
Issuance of common stock
from atm offering,...
$22,568K
Proceeds from the
issuance of common stock,...
$6,938K
Proceeds from issuance of
common stock in...
$32K
Net cash (used in)
provided by investing...
$50,960K
Net cash provided by
financing activities
$25,267K
Canceled cashflow
$4,271K
Net decrease in cash
and cash...
$33,653K
Canceled cashflow
$42,574K
Stock-based compensation
$5,256K
Non-cash finance lease
expense
$4,022K
Non-cash operating lease
expense
$978K
Depreciation
$337K
Accretion of operating
lease liabilities
$81K
Loss on foreign
currency exchange rates
$19K
Principal payments on
finance leases
$4,271K
Net cash used in
operating activities
-$42,561K
Effect of exchange rate
changes on cash and cash...
-$13K
Canceled cashflow
$10,693K
Net loss
-$43,515K
Accrued Liabilities And
Other Operating...
-$7,281K
Lease liabilities
-$1,057K
Prepaid expenses and
other current assets
$409K
Amortization of discount on
investments
$368K
Accounts payable
-$269K
Interest Payable Net
-$241K
Other assets
$114K
Back
Back
Cash Flow
Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. (CABA)
source: myfinsight.com